Regencell Bioscience is exploding higher today, reversing recent volatility that saw the stock trade down 6.8% earlier this week.
While the company has experienced significant fluctuations in trading volume, including a session where 234,856 shares changed hands, there is no specific company-level news or regulatory filing to account for the current move. The stock is instead participating in a broader rotation into healthcare, as evidenced by ga